Silvana Martino Selected Research

Estrogen Receptors

1/2019	Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
9/2015	Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).
3/2012	Prognostic value of basal phenotype in HER2-overexpressing breast cancer.
9/2008	Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.
10/2007	HER2 and response to paclitaxel in node-positive breast cancer.
5/2007	Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
4/2006	Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.
12/2004	Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
9/2004	HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study.
1/2004	The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvana Martino Research Topics

Disease

70	Breast Neoplasms (Breast Cancer) 12/2020 - 06/2002
42	Neoplasms (Cancer) 12/2020 - 03/2003
6	Osteoporosis 07/2008 - 11/2003
3	Infections 01/2020 - 09/2002
3	Necrosis 10/2017 - 05/2008
3	Leukemia 11/2012 - 04/2003
3	Heart Failure 12/2009 - 01/2004
2	Lung Diseases (Lung Disease) 01/2020 - 05/2007
2	Dermatomyositis (Dermatopolymyositis) 05/2019 - 01/2011
2	Uveitis 07/2018 - 01/2018
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2018 - 01/2018
2	Obesity 07/2015 - 12/2012
2	Triple Negative Breast Neoplasms 07/2015 - 11/2011
2	Vasculitis (Vasculitides) 01/2015 - 04/2010
2	Chronic Granulomatous Disease 06/2014 - 04/2013
2	Arthritis (Polyarthritis) 05/2013 - 11/2003
2	Localized Scleroderma (Morphea) 12/2012 - 07/2011
2	Neutropenia 11/2010 - 12/2009
2	Thromboembolism 12/2009 - 12/2004
2	Hot Flashes 04/2008 - 11/2003
2	Wiskott-Aldrich Syndrome 11/2006 - 08/2002
2	Neoplasm Metastasis (Metastasis) 09/2006 - 06/2002
1	Premature Menopause 01/2019
1	Rare Diseases (Rare Disease) 01/2018
1	Skin Manifestations 10/2017
1	Primary Immunodeficiency Diseases 03/2017
1	Nasopharyngeal Carcinoma 09/2016
1	Burkitt Lymphoma (Burkitt's Lymphoma) 09/2016
1	Hodgkin Disease (Hodgkin's Disease) 09/2016
1	Bruton type agammaglobulinemia 09/2016
1	Inflammation (Inflammations) 07/2016
1	Osteomyelitis 07/2016
1	Body Weight (Weight, Body) 09/2015
1	Hematuria 01/2015
1	Proteinuria 01/2015
1	Lupus Nephritis 01/2015
1	Atypical Hemolytic Uremic Syndrome 01/2015
1	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2014
1	Congenital Heart Defects (Congenital Heart Defect) 01/2014
1	Pyogenic arthritis, pyoderma gangrenosum, and acne 05/2013
1	autosomal dominant familial Periodic fever 05/2013
1	Cryopyrin-Associated Periodic Syndromes 05/2013
1	Lymphadenitis (Adenitis) 05/2013

Drug/Important Bio-Agent (IBA)

30	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 02/2003
29	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 01/2003
23	Tamoxifen FDA LinkGeneric 07/2018 - 03/2003
23	Hormones (Hormone)IBA 07/2015 - 03/2003
21	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 02/2003
12	Trastuzumab (Herceptin)FDA Link 12/2020 - 06/2002
11	Estrogen ReceptorsIBA 01/2019 - 03/2003
8	ErbB Receptors (EGF Receptor)IBA 07/2015 - 09/2004
8	Letrozole (Femara)FDA LinkGeneric 04/2008 - 11/2003
7	Methotrexate (Mexate)FDA LinkGeneric 05/2019 - 01/2003
6	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2003
6	AnthracyclinesIBA 01/2016 - 02/2007
6	human ERBB2 proteinIBA 11/2014 - 06/2009
6	Proteins (Proteins, Gene)FDA Link 10/2013 - 06/2002
5	Raloxifene Hydrochloride (Evista)FDA Link 07/2008 - 01/2004
4	Pharmaceutical PreparationsIBA 01/2018 - 07/2006
4	Docetaxel (Taxotere)FDA Link 07/2015 - 04/2008
4	Estrogens (Estrogen)FDA Link 01/2015 - 01/2004
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 05/2007
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2019 - 04/2010
3	Prednisone (Sone)FDA LinkGeneric 05/2019 - 01/2003
3	Goserelin (Zoladex)FDA Link 01/2019 - 09/2005
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 05/2007
3	exemestane (Aromasin)FDA Link 07/2018 - 07/2014
3	Biological ProductsIBA 07/2018 - 03/2012
3	taxaneIBA 01/2016 - 09/2012
3	B 31IBA 11/2014 - 10/2005
2	Aromatase InhibitorsIBA 07/2018 - 07/2014
2	Immunoglobulin G (IgG)IBA 03/2017 - 09/2002
2	MicroRNAs (MicroRNA)IBA 09/2016 - 07/2016
2	RNA (Ribonucleic Acid)IBA 11/2011 - 12/2009
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2007 - 09/2002
1	GlucocorticoidsIBA 05/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2018
1	Antirheumatic Agents (DMARD)IBA 07/2018
1	Adalimumab (Humira)FDA Link 01/2018
1	Infliximab (Remicade)FDA Link 01/2018
1	Thalidomide (Thalomid)FDA Link 10/2017
1	Adenosine DeaminaseIBA 10/2017
1	Diphosphonates (Bisphosphonates)IBA 07/2016
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2015
1	eculizumab FDA Link 01/2015
1	Hematoxylin (Haematoxylon)IBA 09/2014
1	NADPH Oxidase 2IBA 06/2014
1	Phosphorus (Red Phosphorus)IBA 01/2014
1	CalciumIBA 01/2014
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 06/2013
1	Deficiency of interleukin-1 receptor antagonistIBA 05/2013

Therapy/Procedure

37	Therapeutics 12/2020 - 06/2002
26	Drug Therapy (Chemotherapy) 01/2019 - 01/2003
20	Adjuvant Chemotherapy 01/2019 - 01/2003
3	Combination Drug Therapy (Combination Chemotherapy) 11/2014 - 01/2003
3	Radiotherapy 07/2012 - 03/2003
2	Segmental Mastectomy (Lumpectomy) 05/2007 - 03/2003
1	Duration of Therapy 07/2018
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Plasma Exchange 01/2015